BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25216227)

  • 1. Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist.
    Rosado FG; Oliveira JL; Sohani AR; Schroyens W; Sykes DB; Kenderian SS; Lacy MQ; Kyle RA; Hoyer JD
    Mod Pathol; 2015 Mar; 28(3):367-72. PubMed ID: 25216227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEMPI Syndrome: Erythrocytosis in Plasma Cell Dyscrasia.
    Zhang X; Fang M
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):724-730. PubMed ID: 30100329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEMPI syndrome: A clinical, light-microscopic and phenotypic evaluation with review of the literature.
    Kalomeris TA; Grossman ME; Tepler J; Magro CM
    J Cutan Pathol; 2024 Apr; 51(4):299-305. PubMed ID: 38102936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: a 37-year-old male with telangiectasias, polycythemia vera, perinephric fluid collections, and intrapulmonary shunting.
    Khan J; Sykes DB
    BMC Hematol; 2014; 14(1):11. PubMed ID: 25143825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Next-Generation Sequencing Testing in a Patient with TEMPI Syndrome.
    Nunes Rosado FG; Lekovic D; Gagan J; Malter J; Chen W; Sykes DB
    Lab Med; 2023 Sep; 54(5):546-549. PubMed ID: 36864546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEMPI Syndrome: Update on Clinical Features, Management, and Pathogenesis.
    Xu J; Liu W; Fan F; Zhang B; Zhao F; Hu Y; Sun C
    Front Endocrinol (Lausanne); 2022; 13():886961. PubMed ID: 35663307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TEMPI syndrome.
    Sykes DB; O'Connell C; Schroyens W
    Blood; 2020 Apr; 135(15):1199-1203. PubMed ID: 32108223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome.
    Sun C; Xu J; Zhang B; Huang H; Chen L; Yan H; Xu A; Zhao F; Huang D; Liu L; Li J; Hu Y
    Blood Adv; 2021 Jun; 5(12):2563-2568. PubMed ID: 34129019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.
    Percy MJ; Scott LM; Erber WN; Harrison CN; Reilly JT; Jones FG; Green AR; McMullin MF
    Haematologica; 2007 Dec; 92(12):1607-14. PubMed ID: 18055983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of TEMPI syndrome and leukocytoclastic vasculitis successfully treated with autologous stem cell transplantation.
    Nappi D; Tauber M; Sykes D
    EJHaem; 2022 Nov; 3(4):1385-1387. PubMed ID: 36467823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POEMS Syndrome: Bone Marrow, Laboratory, and Clinical Findings in 24 Korean Patients.
    Shim H; Seol CA; Park CJ; Cho YU; Seo EJ; Lee JH; Yoon DH; Suh CW; Park SH; Jang S
    Ann Lab Med; 2019 Nov; 39(6):561-565. PubMed ID: 31240884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: TEMPI syndrome: Report of three cases and treatment follow-up.
    Xu ZF; Ruan J; Chang L; Wu S; Lin J; Wang W; Cao X; Zhang L; Li J; Zhou D; Zhang W
    Front Oncol; 2022; 12():949647. PubMed ID: 35992844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
    Lakey MA; Pardanani A; Hoyer JD; Nguyen PL; Lasho TL; Tefferi A; Hanson CA
    Am J Clin Pathol; 2010 Jun; 133(6):942-8. PubMed ID: 20472853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency.
    Belizaire R; Sykes DB; Chen YB; Spitzer TR; Makar RS
    Transfusion; 2015 Sep; 55(9):2142-8. PubMed ID: 25911963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients.
    Dao LN; Hanson CA; Dispenzieri A; Morice WG; Kurtin PJ; Hoyer JD
    Blood; 2011 Jun; 117(24):6438-44. PubMed ID: 21385854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
    Scott LM; Tong W; Levine RL; Scott MA; Beer PA; Stratton MR; Futreal PA; Erber WN; McMullin MF; Harrison CN; Warren AJ; Gilliland DG; Lodish HF; Green AR
    N Engl J Med; 2007 Feb; 356(5):459-68. PubMed ID: 17267906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome, associated with preceding polycythemia vera. A case report and review of the literature.
    Tsujimura T; Kishino BI; Itatani H; Aozasa K; Matsumoto K
    Acta Pathol Jpn; 1988 Oct; 38(10):1337-44. PubMed ID: 3064544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature.
    Undar L; Atas U; Iltar U; Salim O; Yucel OK; Alpsoy E
    Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):702-707. PubMed ID: 35624059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
    Miralles GD; O'Fallon JR; Talley NJ
    N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.